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Abstract
Background: The aims of the study was to assess the prevalence of diagnosed insomnia and the agreement
between patient- and clinician-reported sleep disturbance and use of prescribed hypnotic medication in patients in
treatment for mental disorders.
Methods: We used three cross-sectional, multicenter data-sets from 2002, 2005, and 2008. Data-set 1 included
diagnostic codes from 93% of all patients receiving treatment in mental health care in Norway (N = 40261). Data-
sets 2 (N = 1065) and 3 (N = 1181) included diagnostic codes, patient- and clinician-reported sleep disturbance,
and use of prescribed hypnotic medication from patients in 8 mental health care centers covering 10% of the
Norwegian population.
Results: 34 patients in data-set 1 and none in data-sets 2 and 3 had a diagnosis of insomnia as a primary or
comorbid diagnosis. In data-sets 2 and 3, 42% and 40% of the patients reported sleep disturbance, whereas 24%
and 13% had clinician-reported sleep disturbance, and 7% and 9% used hypnotics. Patients and clinicians agreed in
29% and 15% of the cases where the patient or the clinician or both had reported sleep disturbance. Positive
predictive value (PPV) of clinicians’ evaluations of patient sleep disturbance was 62% and 53%. When the patient
reported sleep disturbance as one of their most prominent problems PPV was 36% and 37%. Of the patients who
received hypnotic medication, 23% and 29% had neither patient nor clinician-rated sleep disturbance.
Conclusion: When patients meet the criteria for a mental disorder, insomnia is almost never diagnosed, and sleep
disturbance is imprecisely recognized relative to the patients’ experience of sleep disturbance.
Background
Sleep disturbance is likely to be a core feature across sev-
eral mental disorders [1,2]. In patients with depression,
sleep disturbance predicts poorer treatment outcome and
is associated with more suicide attempts [3,4]. Moreover,
40%-70% of patients successfully treated for depression
still experience sleep disturbance after treatment [3,5], and
these patients may be at a higher risk of relapses into new
episodes [6]. This challenges the assumption that the sleep
disturbance will also be improved once the primary mental
disorder is treated. It may be more adequate to assume
that there is a need for specific treatment for sleep distur-
bance for these patients.
Adequate management of insomnia starts with recogni-
tion and diagnostic assessment. There is a risk, however,
that insomnia could become trivialized in mental health
care because it is both a diagnosis as well as a symptom of
several mental disorders. But although many may share
the impression that insomnia is under-recognized by clini-
cians [7,8], the actual data available from medical practice
is limited and ambiguous. Two studies have confirmed
that sleep is seldom documented in medical charts in gen-
eral hospitals [9] or on general medical services [10],
whereas a recent large-scale study concluded that sleep
disturbance is adequately recognized by general practi-
tioners [11]. Only one study has been conducted to test if
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sleep disturbance is clinically recognized in patients with
mental disorders [12]. The authors found that 80 of 100
patients on a psychiatric consultation service had sleep
disorders but disturbed sleep was not mentioned in the
records of 54% of these patients. However, the study was
conducted in the early 1980s and had limited external
validity. The state of sleep in psychiatry might be different
30 years later. Thus, even though 50% to 80% of patients
with mental disorders have sleep disturbance [13], there is
currently limited empirical knowledge about diagnostic
assessment, clinical recognition and treatment for this
large group of patients.
As the DSM and the ICD will be revised during the next
years there is currently a need for data that can inform
this revision process [14]. The primary users of these diag-
nostic systems are mental health care personnel and gen-
eral medical clinicians and the classifications should
therefore be meaningful for these groups [14]. A basic test
of clinical utility is to explore whether clinicians in mental
health care use the insomnia diagnosis. However, because
insomnia is also a symptom of several mental disorders,
there is a possibility that clinicians could recognize and
treat sleep disturbance without diagnosing it.
The aims of this study were therefore to examine
whether insomnia is diagnosed and whether sleep dis-
turbance is recognized and treated in patients with men-
tal disorders. We used three large, cross sectional,
multicenter data-sets for this purpose.
Methods
Data-set 1 included demographic information and clinical
diagnostic codes from an estimated 93% of all patients
receiving treatment in mental health care, both private
practice and public health care, in Norway during two
weeks in 2008.
In addition to demographic and clinical diagnostic
assessments, data-sets 2 and 3 also included both clini-
cians’ and patients’ report of sleep disturbance and pre-
scriptions of hypnotic medication. Data-sets 2 and 3 were
conducted at eight public mental health centers during
eight weeks in 2002 and four weeks in 2005, respectively.
The centers were selected to be representative for the
country as a whole and the catchment areas covered about
10% of the Norwegian population. The centers covered
both rural and urban areas as well as northern and south-
ern parts of the country. The data collections were com-
missioned by the Norwegian Department of Health to
evaluate the state of the National Mental Health Care
System and were not designed specifically to evaluate
sleep disturbance in patients with mental disorders.
Data-sets 1, 2 and 3 were used to assess the prevalence
of clinically diagnosed insomnia. Data-sets 2 and 3 were
also used to assess the agreement between clinician and
patient reported sleep disturbance and prescription of
hypnotic medication. The analyses were replicated in the
data-sets to test the reliability of the findings.
Participants
Data-set 1 included 40 261 patients. Patients were between
18 and 103 years old. See table 1 for demographic data.
In data-set 2, a total of 3 497 patients were enrolled and
1 065 patients (30%) were included in the current study as
they agreed to have their self-report linked to their clini-
cian’s diagnoses and symptom reports and treatment.
Patients were between 18 and 85 years old.
In data-set 3, a total of 3041 patients were enrolled and
1181 patients (39%) were included as they agreed to have
their self-report linked to their clinician’s diagnoses and
symptom reports and treatment. Patients were between 18
and 82 years old.
Assessments
Data collection
All data collections were commissioned by the Norwegian
Department of Health and conducted by an independent
research institution, SINTEF Technology and Society.
Diagnosis of insomnia
Primary and one (data-set 1) or two (data-sets 2 and 3)
additional ICD-10 [15] diagnoses were recorded by the
clinicians in charge. The procedure for the diagnostic eva-
luation varied within and between clinics and mirrored
clinical practice. There were missing diagnoses for 46
patients in data-set 2 and 241 in data-set 3. Patients with a
diagnosis of F51.0 Non-organic insomnia as either a pri-
mary, secondary or tertiary diagnosis were categorized as
having a diagnosed insomnia. See table 2 for diagnostic
criteria.
Patient-reported sleep disturbance
Patients completed the Symptom Checklist - 25 (SCL-
25) in data-set 2 and the Symptom Checklist - 10 in
data-set 3 (SCL-10). Both are short versions of the SCL-
90-R and the Norwegian translations have satisfactory
validity and reliability [16]. The SCL-25 consists of 25
Table 1 Sample characteristics in the three data-sets
included in the study
Data-set 1
(N = 40261)
Data-set 2
(N = 1065)
Data-set 3
(N = 1181)
Age, mean (s.d.) 40.2 (14.2) 39.4 (12.1) 39.6 (12.0)
N (%) n (%) n (%)
Gender
Female 24702 (61.4) 674 (63.3) 745 (63.1)
Male 14598 (36.3) 382 (35.9) 407 (34.5)
Type of treatment
Outpatient 31627 (78.6) 903 (84.8) 911 (77.1)
Day treatment 1801 (4.5) 66 (6.2) 129 (10.9)
Inpatient 4079 (10.1) 76 (7.1) 138 (11.7)
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items, and the SCL-10 consists of 10 items, describing
psychiatric symptoms rated on a 4-point scale (1 = not
at all, 4 = very severe). All items on the SCL-10 are pre-
sent in the SCL-25.
Three items measure sleep disturbance on the SCL-90R.
On the SCL-25 and the SCL-10, these three have been
reduced to one item measuring the severity of sleep distur-
bance. This item was used to assess patient rated level of
sleep disturbance. Patients who scored 3 or 4 (quite severe
or very severe) on this item were categorized as having
patient-rated sleep disturbance.
Clinician-reported sleep disturbance
The clinicians used the Health of Nations Outcome
Scales (HoNOS) to evaluate the patients. The HoNOS is
a 12-item instrument measuring behavior, impairment,
symptoms and social functioning for patients with mental
disorders [17]. HoNOS item 8 requires the clinicians to
identify mental or behavioral problems from a list of 10:
phobic, anxiety, obsessive-compulsive, stress, dissociative,
somatoform, eating, sleep disturbance, sexual, or other.
The clinicians reported the three most prominent pro-
blems in data-set 2 and the most prominent problem in
data-set 3 on HoNOS item 8. The HoNOS item 8 was
rated on a binary scale for the current study (present or
not present). Patients who the clinicians indicated had a
sleep disturbance on HoNOS Item 8 were categorized as
having clinician-rated sleep disturbance.
Hypnotic medication
Patients who were prescribed one or more of the follow-
ing medications: Zopiclone, Zolpidem, Nitrazepam,
Flunitrazepam, Trimeprazime and Promethazine.
Statistical analyses
The clinicians’ accuracy in recognizing the patients’
sleep disturbance was reported as positive and negative
predictive value. The following definitions were used.
True Positive (TP) means both the patient and clinician
had reported sleep disturbance; False Positive (FP) means
the patient had not reported sleep disturbance but the
clinician had; False Negative (FN) means that the patient
had reported sleep disturbance but the clinician had not;
True Negative (TN) means the both the patient and the
clinician had not reported sleep disturbance.
Positive predictive value was calculated using the
equation: TP/(TP + FP). This indicates the proportion
of the clinicians’ evaluations of sleep disturbance that
were correct, i. e. similar to patient experience. Negative
predictive value was calculated using the equation: TN/
(FN + TN). This indicates the proportion of clinicians’
evaluations of no sleep problem that were correct.
Differences between data-set 2 and 3 were calculated
using Mann-Whitney U-tests. Diagnostic differences in
agreement were calculated using Chi-squared analyses.
Because of the large sample size and multiple tests, level
of statistical significance was set to p < 0.001.
Ethics
The three studies were approved by The Regional Com-
mittee for Medical Research Ethics, Middle Norway.
Results
Diagnostic prevalence
In data-set 1, 34 of 40 621 patients (0.08%, [95% CI: 0.05%
- 0.11%]) had received an ICD-10 diagnosis of insomnia.
In data-sets 2 and 3 no patients had received an ICD-10
diagnosis of insomnia.
Prevalence of patient and clinician-reported sleep
disturbance and use of hypnotics
Table 3 indicates the prevalence of patient and clinician-
reported sleep disturbance and prescription of hypnotics
in data-sets 2 and 3.
233 patients (22% [19% - 24%]) in data-set 2 and 299
patients (25% [23% - 28%]) in data-set 3, reported sleep
disturbance to be one of the most prominent symptoms,
Table 2 ICD-10 diagnostic criteria for F51.0 Non-organic Insomnia
Symptom Individual complaints of difficulty falling asleep, difficulty maintaining sleep, or non-refreshing sleep.
Duration At least three days a week for at least one month.
Consequence The sleep disturbance results in marked personal distress or interference with personal functioning in daily living.
Comorbidity If other mental disturbances are present, Insomnia should be coded as an additional disturbance if either a) sleep disturbance is one
of the patient’s most prominent complaints, or b) if the sleep disturbance also occurs in periods without symptoms of other mental
disturbance.
Exclusion There is no known causative organic factor. If the sleep disturbance only occurs during episodes of other mental disturbance, the
primary mental disturbance should be coded.
Table 3 Prevalence of sleep disturbance in patients with
mental disorders
Data-set 2
(N = 1065)
Data-set 3
(N = 1181)
Sleep disturbance n % 95% CI n % 95% CI
Patient-reported 447 42 39 - 45 475 40 37 - 43
Clinician-reported* 255 24 21 - 27 152 13 11 - 15
Hypnotic medication 73 7 5 - 8 106 9 7 - 11
* Please note that a more conservative measure of clinician-reported sleep
disturbance was used in data-set 3 compared to data-set 2.
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as indicated by a score of 3 or above on the SCL sleep
item and scores of less than, or equal to, the score of
sleep disturbance on the remaining 24 symptoms on the
SCL-25 (data-set 2) or 9 symptoms on the SCL-10
(data-set 3). In addition, 331 patients (31%, [28% - 34%])
in data-set 2 and 416 patients (35% [32% - 38%]) in
data-set 3, reported sleep difficulties of mild symptom
severity (score of 2 on the SCL sleep item).
There were more patients with clinician-rated sleep dis-
turbance in data-set 2 compared to data-set 3 (p < 0.001).
There were no differences between the two data-sets in
patient-rated sleep disturbance and prescription of hypno-
tic medication.
Demographic differences
There were no differences between patients in any of the
sleep disturbance categories or prescription of hypnotic
medication and other patients in age, gender, type of
treatment, or between the eight different clinics in either
data-set 2 or 3.
Agreement
Of the patients with either patient- or clinician rated
sleep disturbance, patients and clinicians agreed in 29%
(25% - 33%) of the cases in data-set 2 and 15% (12% -
18%) in data-set 3.
The average positive predictive value (PPV) of clini-
cians’ evaluations of the patients’ sleep disturbance was
62% (58% - 66%) in data-set 2 and 53% (49% - 57%) in
data-set 3. Average negative predictive value (NPV) was
64% (60% - 68%) in data-set 2 and 61% (57% - 65%) in
data-set 3.
To test if clinicians had higher precision rate if the
patient experienced sleep disturbance as one of their most
prominent symptoms, we also calculated PPV and NPV
for patients with self-reported sleep disturbance as one of
the most prominent symptoms. For these patients, PPV
was 36% (30% - 42%) in data-set 2 and 37% (32% - 42%) in
data-set 3. NPV was 83% (78% - 87%) in data-set 2 and
76% (71% - 81%) in data-set 3.
Among the patients who were prescribed hypnotic
medication, 55% (44% - 66%) had a clinician reported
sleep disturbance in data-set 2 and 26% (18% - 34%) in
data-set 3. In addition, 23% (13% - 33%) in data-set 2 and
29% (20% - 38%) in data-set 3 had neither patient- nor
clinician-rated sleep disturbance.
The overlap between the patients with self-reported
sleep disturbance, the patients with clinician-rated sleep
disturbance and the patients who were prescribed hypno-
tic medication in data-set 2 are described in Figure 1.
The overlap between patients with a self-reported sleep
disturbance as one of the most prominent symptoms,
patients with clinician rated sleep disturbance and
patients who were prescribed hypnotic medication in
data-set 3 are described in Figure 2.
Because clinicians might be more likely to assess sleep
disturbance in certain disorders, we conducted c2 for
selected diagnostic groups (substance abuse, schizophre-
nia, bipolar disorder, depressive episode, recurrent depres-
sive episode, anxiety disorders, adjustment disorders and
personality disorders) in chapter V of the ICD-10 to test if
there were differences in agreement in these patient
groups. There were no differences in agreement in any
diagnostic group in data-set 2. In data-set 3, agreement
was higher when the patient had a diagnosis of depressive
episode (c2(1) = 31.6, p ≤ 0.001) compared to other
patients.
Discussion
Using three independent and nationally representative
data-sets, we found that the diagnosis of insomnia was vir-
tually non-existent in patients with mental disorders. Only
34 of 42507 patients had a diagnosis of insomnia as either
a primary or a comorbid diagnosis. However, about 40%
of all patients experienced severe sleep disturbance and at
least 22% reported this to be one of their most prominent
problems. Although they did not diagnose it, clinicians
indicated that 24% of their patients had sleep disturbance
as a prominent problem. We found a notable discrepancy
between the clinicians’ report and the patients’ report of
sleep disturbance. The patients and clinicians agreed in
less than 30% of the cases where either the patients or
clinicians had reported sleep disturbance. The probability
of the patients themselves experiencing sleep disturbance
when the clinician reported this, was less than 62%. This
probability was surprisingly even lower when the patient
experienced their sleep disturbance to be one of their
most prominent symptoms, with a predictive value of less
than 37%. Thus, the precision of clinician-rated sleep dis-
turbance was close-to-chance when compared to the
patient report. Of the patients who used hypnotics, 55%
reported having sleep disturbance whereas 23% had
neither clinician nor patient reported sleep disturbance.
These findings were replicated with only minor differences
in the different samples.
The diagnostic findings are at odds with findings from
epidemiological studies where the prevalence has been
reported to be about 100 times higher [18-20]. However,
our findings are in line with two previous studies where
large discrepancies between findings from epidemiologi-
cal studies and diagnostic practice in clinical settings
have been reported [21,22]. Although the diagnostic
recommendation in the ICD-10 is to code insomnia as a
comorbid disorder if it is one of the most prominent
symptoms, our findings indicate that clinicians are reluc-
tant to use these recommendations.
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Underlying this may be a long-standing issue of
whether insomnia should be regarded as a symptom of
other disorders or as a disorder in it self. Clinicians may
not find it relevant to code insomnia as a comorbid
condition as they regard it as a part of the primary men-
tal disorder. If clinicians do not find the diagnosis of
insomnia relevant to their practice, this may raise con-
cerns about the usefulness of the diagnosis in its current
Patient-reported sleep disturbance
n = 447 (42%) Prescribed hypotics
n = 73 (7%)
Clinician-rated
sleep disturbance
n = 255 (24%)
All patients
N = 1065
25%
13%
8%
2%
2%
2%
1%
Figure 1 Venn diagram describing agreement in data-set 2. The overlap between the patients with self-reported sleep disturbance, patients
with clinician reported sleep disturbance and patients who were prescribed hypnotic medication, in data-set 2.
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form. In this respect it is interesting to note that the
online draft of the DSM-5 proposes to remove the diag-
nosis of Insomnia Related to Another Mental Distur-
bance and only operate with the diagnosis of Insomnia.
The proposed change in the DSM reflects a change in
paradigm from thinking of insomnia as a symptom to
thinking of insomnia as a disorder. It recommends cod-
ing Insomnia Disorder if the criteria are fulfilled
Patient-reported sleep disturbance
as one of the most prominent symptoms
n = 299 (25%)
Prescribed hypnotics
n = 106 (9%)
Clinician-reported
sleep disturbance
n = 152 (13%)
18%
3%
1%
3%
4%
1%
7%
All patients
N = 1181
Figure 2 Venn diagram describing agreement in data-set 3. The overlap between the patients with self-reported sleep disturbance as one
of the most prominent problems, patients with clinician reported sleep disturbance and patients who were prescribed hypnotic medication, in
data-set 3.
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regardless of meeting criteria for other mental disorders,
because determining the cause or consequence of the
problem is clinically difficult, if not impossible [23].
Patient report of sleep disturbance was higher than
what is found in the general population using similar
measures [19], but in agreement with other studies from
patients with mental disorders [13]. Hypnotic medication
was, relative to previous studies [24,25], seldom pre-
scribed to the patients in the current study. Less than 9%
of all patients were prescribed such medication compared
to 7% of the general population in Norway in the same
period [20]. Patients with mental disorders are likely to
be prescribed other medications that have effects on
sleep, such as some anti-depressants or anti-psychotic
medication that could make hypnotic medication less
needed. Still, it is curious that at least 23% of the patients
who were prescribed hypnotic medication had neither
self-reported nor clinician-reported sleep disturbance.
This could indicate that patients who are being pre-
scribed hypnotics stay on hypnotics after the sleep distur-
bance has been treated.
The low recognition of sleep disturbance raises ques-
tions concerning education and training of health care
professionals. Although a call for improved education
about sleep was made in the 1980s when similar findings
were reported [12], the situation does not seem to have
improved. Physician training in the recognition of sleep
specific symptoms has been reported to be minimal [26].
Similarly, a survey of 212 directors of graduate and intern-
ship programs of clinical psychology revealed that only 6%
of the programs offered courses in sleep and most
reported that their institution was ineffective in providing
sleep education [27]. Moreover, doctors seldom ask about
sleep in clinical interviews [28], and patients with sleep
disturbance infrequently report this to their clinicians
[29,30]. This makes it important for health care profes-
sionals to have knowledge about the features of sleep.
Limitations
There is a possibility of sampling bias in data-sets 2 and 3
as about two-thirds of the original sample of patients did
not agree to have their self-report linked to the clinician-
report. This could be an artifact of the procedures. The
patients had to specifically indicate that they wanted to
have their scores linked to their clinicians’ ratings, rather
than having to indicate if they did not want to have their
scores linked. This difference could have had a large
impact on patient participation [31].
Clinicians in data-set 3 were asked to only indicate the
most prominent problem the patient experienced com-
pared to the three most prominent problems reported by
clinicians in data-set 2. This gave a lower prevalence of
clinician-rated sleep disturbance in data-set 3 compared
to data-set 2. In both data-sets clinicians have therefore
only indicated the patients who they regard as having
sleep disturbance as one of their most prominent pro-
blems. The study was not primarily designed to measure
sleep disturbance in mental health care and we might
have found a higher prevalence of clinician-rated sleep
disturbance if we had utilized a survey directly inquiring
about sleep symptoms. This could have resulted in higher
agreement and different predictive values for clinician’s
evaluations. However, our finding that even when clini-
cians evaluate sleep disturbance to be one of the most
prominent problems, there is still a very low agreement
between patients and clinicians. Especially as the predic-
tive value of the clinicians’ report was less than chance
for the patients who reported sleep disturbance as one of
their most prominent problems.
The use of a single item measuring sleep disturbance is
another limitation. This means that it is not possible to
discern if there were differences in agreement between
sleep onset or sleep maintenance problems or if the
patients experienced other kinds of sleep disturbance.
Finally, although we have assessed patients who
received hypnotic medication, there might be a propor-
tion of the patients who received alternate medication
or non-pharmacological interventions for their sleep
disturbance.
Conclusion
When patients meet the criteria for a mental disorder,
insomnia is almost never diagnosed, and sleep distur-
bance is imprecisely recognized relative to the patients’
experience of sleep disturbance.
Our results, rather than taken as criticism of indivi-
dual health care professionals, should be interpreted as
a call for improved teaching and better understanding of
sleep disturbance and its treatment. Moreover, the non-
existence of the insomnia diagnosis in three different
clinical samples may not only be a result of insufficient
training, but also indicate an area where revising the
ICD and DSM systems could be useful. The suggested
change in the DSM-5 of coding insomnia is likely to be
favorable compared to the current system and could be
considered also in the ICD-11.
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